577 filings
Page 9 of 29
6-K
xrgfkme5x s47a86y
30 Nov 16
Portage Announces Spin-out of Eygen Limited
12:00am
6-K
gs4fpy78e9nch8s n2
28 Nov 16
Interim Financials for the Three and Six Months Ended September 30, 2016
12:00am
6-K
gjethujz
3 Nov 16
Biohaven Raises $80 Million
12:00am
6-K
zh3pv 39ae6kojs
21 Sep 16
Chairman's Letter to Shareholders
12:00am
6-K
kbm48kxqr eop3p
30 Aug 16
Consolidated Interim Financials for the Three Months Ended June 30, 2016 and Management Discussion and Analysis for the Same Period
12:00am
6-K
iwac257 k4
5 Aug 16
Portage Appoints a New Director
12:00am
6-K
zbgomf9ma540k6loaj
21 Jul 16
Current report (foreign)
12:00am
6-K
l114r s5ui5xnoj0kbsu
7 Jul 16
Fda Clears Biohaven's Ind for BHV-4157 Ans Portage to Hold Investor Conference Call
12:00am
6-K
e430sa8m0h1n
26 May 16
Portage Announces Orphan Drug Designation Request Granted Fto Biohaven for BHV 4157
12:00am
6-K
vsjkw6v
27 Apr 16
Biohaven Appoints Chief Commercial Officer
12:00am
6-K
ikd9 hmxvf9dt8w
7 Apr 16
Portage Provides Corporate Updates
12:00am
6-K
1uqnhrz38 c7rzlqmfe
23 Mar 16
Portage Invests Further In Biohaven
12:00am
6-K
iefxu
21 Mar 16
Orphan Drug Designation Received by Biohaven
12:00am
6-K
oyodt uwwb4100
14 Mar 16
Announcement of Proposed Private Placement
12:00am
6-K
kab1ug cya3sq2dx0b
26 Feb 16
Third Quarter 16 Financials and Mda
12:00am
6-K
3xm21d0bsvzgmxgh
25 Feb 16
Expedited Development Path for BHV 0223 for Biohaven
12:00am
6-K
p8kc vlufx2
25 Feb 16
Positive Results from Phase 1 Study with BHV-0223
12:00am
6-K
j19euh629my3b 59b2
8 Feb 16
Notice of Record and Mailing Date
12:00am
6-K
b0by59tlh3daguue
25 Jan 16
Portage Provides PPL Updates
12:00am